Xoft (Manufacturing, Medical Devices) — Funding, Investors & Signals 2026

Xoft

Founded 1998

San Jose, United States 52 employees Debt Financing Total: $130.70M Manufacturing, Medical Devices

Xoft is a cutting-edge medical technology startup founded in 1998 and based in the United States. The company has developed the Xoft® Electronic Brachytherapy System®, which has received FDA clearance for treating various types of cancer, such as non-melanoma skin cancer, brain tumors, early stage breast cancer, and gynecological cancers. This innovative system uses a proprietary miniaturized x-ray as the radiation source, delivering precise treatment directly to cancerous areas while minimizing damage to healthy tissue and organs. The Xoft System has the advantage of being isotope-free, enabling it to be used in a wider range of clinical settings. It can be administered as a single course of radiation therapy during surgery through intraoperative radiation therapy (IORT) or in the form of partial breast irradiation (APBI). One distinguishing feature of the Xoft System is its mobility and small size, meaning it does not require a shielded environment and can be utilized in virtually any clinical setting. The latest recorded investment in Xoft stands at $968.06K, received in the form of debt financing on 12 July 2010. The company is currently undergoing a post-market study to evaluate the safety and efficacy of IORT with the Xoft System. For more information, interested parties can visit www.xoftinc.com. Overall, Xoft presents a compelling offering in the field of cancer treatment, leveraging innovative technology to provide more precise and adaptable radiation therapy solutions, sparking interest from potential venture capital candidates seeking disruptive advancements in the healthcare industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	$968.06K	-		12 Jul 2010
Debt Financing	$10.33M	-		12 Jun 2009
Series E	$25.00M	5		05 Aug 2008
Series D	$33.20M	10	Frantz Medical	05 Apr 2007
Series C	$20.10M	5		05 Jan 2006

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

$968.06K

12 Jul 2010

Debt Financing

$10.33M

12 Jun 2009

Series E

$25.00M

05 Aug 2008

Series D

$33.20M

Frantz Medical

05 Apr 2007

Series C

$20.10M

05 Jan 2006

FAQ About Xoft

The Xoft® Electronic Brachytherapy System® is an isotope-free radiation treatment cleared by the FDA for use anywhere in the body, including non-melanoma skin cancer, brain tumors, early stage breast cancer, and gynecological cancers. It utilizes a proprietary miniaturized x-ray as the radiation sou...

Xoft was founded in 1998.

Xoft is headquartered in San Jose, United States.

Xoft operates in the following industries: Manufacturing, Medical Devices.

Xoft has approximately 52 employees.

Xoft has completed 8 funding rounds, raising a total of $130.70M. The latest funding stage is Debt Financing.

Top alternatives and competitors to Xoft include Golden Gate Cancer Center, Cianna Medical, Marvel Medtech, Advanced Radiation Therapy, Cvergenx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Xoft and Golden Gate Cancer Center are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Xoft

General Information

Track Xoft

Discover More

About Xoft

Funding Rounds & Investors (8)

Xoft Alternatives & Competitors

FAQ About Xoft

Don't just browse. Track.